Human Health Therapeutics Research Centre, National Research Council Canada, 6100 Royalmount Avenue, Montreal, QC, H4P 2R2, Canada.
Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.
Sci Rep. 2023 Oct 1;13(1):16498. doi: 10.1038/s41598-023-43661-2.
SARS-CoV-2 subunit vaccines continue to be the focus of intense clinical development worldwide. Protein antigens in these vaccines most commonly consist of the spike ectodomain fused to a heterologous trimerization sequence, designed to mimic the compact, prefusion conformation of the spike on the virus surface. Since 2020, we have produced dozens of such constructs in CHO cells, consisting of spike variants with different mutations fused to different trimerization sequences. This set of constructs displayed notable conformational heterogeneity, with two distinct trimer species consistently detected by analytical size exclusion chromatography. A recent report showed that spike ectodomain fusion constructs can adopt an alternative trimer conformation consisting of loosely associated ectodomain protomers. Here, we applied multiple biophysical and immunological techniques to demonstrate that this alternative conformation is formed to a significant extent by several SARS-CoV-2 variant spike proteins. We have also examined the influence of temperature and pH, which can induce inter-conversion of the two forms. The substantial structural differences between these trimer types may impact their performance as vaccine antigens.
SARS-CoV-2 亚单位疫苗仍然是全球临床开发的重点。这些疫苗中的蛋白抗原最常由融合了异源三聚化序列的刺突外域组成,旨在模拟病毒表面刺突的紧凑、预融合构象。自 2020 年以来,我们已经在 CHO 细胞中生产了数十种这样的构建体,这些构建体由融合了不同三聚化序列的不同突变的刺突变体组成。这组构建体表现出明显的构象异质性,通过分析性尺寸排阻色谱法始终检测到两种不同的三聚体种类。最近的一份报告表明,刺突外域融合构建体可以采用另一种由松散结合的外域原聚体组成的三聚体构象。在这里,我们应用多种生物物理和免疫学技术证明,这种替代构象是由几种 SARS-CoV-2 变体的刺突蛋白在很大程度上形成的。我们还研究了温度和 pH 值的影响,这可能会诱导两种形式的相互转化。这两种三聚体类型之间存在显著的结构差异,可能会影响它们作为疫苗抗原的性能。